Results 251 to 260 of about 32,738 (290)

Hyperthermic Intraperitoneal Chemotherapy for Ovarian and Colorectal Cancer: A Review.

JAMA Oncology, 2021
Importance The peritoneal surface is a common site of disease in ovarian and colorectal cancer. Peritoneal metastases carry a poor prognosis, despite maximal therapeutic efforts, including surgical removal of tumor deposits and intravenous chemotherapy ...
R. V. van Stein, A. Aalbers, G. Sonke, W. V. van Driel   +3 more
semanticscholar   +1 more source

Peritoneal Cancers and Hyperthermic Intraperitoneal Chemotherapy

Surgical Clinics of North America, 2020
Cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy is an aggressive, potentially curative approach used to treat locoregional disease associated with primary and secondary malignancies of the peritoneum. It involves resection of all macroscopic disease larger than 2.5 mm, followed by instillation of hyperthermic chemotherapy ...
Eric, Pletcher, Elizabeth, Gleeson, Daniel, Labow   +2 more
openaire   +2 more sources

Hyperthermic Intraperitoneal Chemotherapy

Advances in Anesthesia, 2005
Cancer treatment frequently requires a multimodality approach, involving surgical resection(s), radiotherapy, and chemotherapy. Advanced surgical approaches allow for the combination of two of these, offering patients intraoperative radiotherapy with surgical resection or intraoperative chemotherapy targeted and limited to a particular body region. The
Alicia M. Kowalski, Thomas B. Dougherty
openaire   +1 more source

Hyperthermic intraperitoneal chemotherapy for treating ovarian cancer

JAAPA, 2021
ABSTRACT Hyperthermic intraperitoneal chemotherapy (HIPEC) has been used for decades as a treatment for disseminated abdominal malignancies, including pseudomyxoma peritonei and peritoneal mesothelioma. HIPEC had been used to treat recurrent ovarian cancer only when curative options were lacking, but new data indicate that it may be suitable ...
Shilpa, Gajarawala, Jessica, Pelkowski, Rose, Dorian, Amanda, Stanton, Tri, Dinh   +4 more
openaire   +2 more sources

Prognosis of poorly cohesive gastric cancer after complete cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (CYTO-CHIP study).

British Journal of Surgery, 2021
BACKGROUND The incidence of gastric poorly cohesive carcinoma (PCC) is increasing. The prognosis for patients with peritoneal metastases remains poor and the role of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) is ...
P. Bonnot, A. Lintis, F. Mercier, N. Benzerdjeb, G. Passot, M. Pocard, B. Meunier, J. Bereder, K. Abboud, F. Marchal, F. Quénet, D. Goéré, S. Msika, C. Arvieux, N. Pirró, R. Wernert, P. Rat, J. Gagnière, J. Lefèvre, T. Courvoisier, R. Kianmanesh, D. Vaudoyer, M. Rivoire, P. Meeus, L. Villeneuve, G. Piessen, O. Glehen   +26 more
semanticscholar   +1 more source

Ventricular tachycardia during hyperthermic intraperitoneal chemotherapy

Anaesthesia, 2009
Summary Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) is used for selected gastrointestinal carcinomas. We report a case of ventricular tachycardia during HIPEC with cisplatin that persisted as long as the chemotherapy solution remained in the intra‐abdominal cavity.
C A, Thix, I, Königsrainer, R, Kind, P, Wied, T H, Schroeder   +4 more
openaire   +2 more sources

Effects of neoadjuvant hyperthermic intraperitoneal chemotherapy on chemotherapy response score and recurrence in high‐grade serous ovarian cancer patients with advanced disease: A multicentre retrospective cohort study

BJOG: an International Journal of Obstetrics and Gynaecology, 2022
To investigate whether the combination of neoadjuvant hyperthermic intraperitoneal chemotherapy (NHIPEC) plus intravenous neoadjuvant chemotherapy (IV NACT) has superior efficacy to IV NACT alone.
Miao-Fang Wu, Jin-xiao Liang, Hui Li, Yan-Fang Ye, Wei Liang, Li-Juan Wang, Bingzhong Zhang, Qing Chen, Zhongqiu Lin, Jing Li   +9 more
semanticscholar   +1 more source

Hyperthermic Intraoperative Intraperitoneal Chemotherapy Safety Considerations

AORN Journal, 1996
ABSTRACTPerioperative staff members encounter many occupational exposure hazards in the workplace. Cytotoxic agent exposure is a relatively new hazard that perioperative staff members are experiencing as more surgeons use hyperthermic intraoperative intraperitoneal chemotherapy (HIIC) to treat patients with abdominopelvic cavity malignancies. Routes of
S K, White, A D, Stephens, P H, Sugarbaker   +2 more
openaire   +2 more sources

Hyperthermic Intraperitoneal Chemotherapy in Platinum-Sensitive Recurrent Ovarian Cancer: A Randomized Trial on Survival Evaluation (HORSE; MITO-18)

Journal of Clinical Oncology
PURPOSE To investigate whether the addition of hyperthermic intraperitoneal chemotherapy (HIPEC) to secondary cytoreductive surgery (SCS) without neoadjuvant chemotherapy has a benefit on progression-free survival (PFS), as opposed to SCS alone in ...
MD PhD Anna Fagotti, MD Barbara Costantini, MD PhD Francesco Fanfani, PhD MSc Diana Giannarelli, MD Pierandrea De Iaco, MD PhD Vito Chiantera, MD Vincenzo Mandato, MD Giorgio Giorda, MD Giovanni Aletti, MD PhD Stefano Greggi, MD PhD A. Myriam Perrone, MD Vanda Salutari, MD Rita Trozzi, MD Giovanni Scambia   +13 more
semanticscholar   +1 more source

Hyperthermic Intraperitoneal Chemotherapy

2017
Peritoneal metastasis in abdominal malignancies is associated with a dismal prognosis. In the past, it was considered inoperable and the patient was considered a candidate for palliative chemotherapy alone. The outcome of systemic chemotherapy is poor with the average survival being 6–8 months.
Nikhil Gupta, Shivendra Singh
openaire   +1 more source